A 10mg vial of TB-500 provides a high-yield unit of synthetic Thymosin Beta-4 sequence material designed for multi-plate cell culture assays and longitudinal animal models. Formulated for precision research environments, this standardized mass allows research teams to establish consistent working concentrations without frequent vial transitions. This technical guide outlines the physical specifications, reconstitution calculations, aliquot preservation protocols, and analytical purity metrics for the 10mg vial format.
A 10mg vial of TB-500 provides a high-yield unit of synthetic Thymosin Beta-4 sequence material designed for multi-plate cell culture assays and longitudinal animal models. Formulated for precision research environments, this standardized mass allows research teams to establish consistent working concentrations without frequent vial transitions. This technical guide outlines the physical specifications, reconstitution calculations, aliquot preservation protocols, and analytical purity metrics for the 10mg vial format.
A 10mg vial of TB-500 contains a high-purity, lyophilized cake of synthetic Thymosin Beta-4 (or its primary active region, LKKTETQ). In laboratory settings, this specific 10mg unit size is predominantly sourced by institutional research groups, academic laboratories, and contract research organizations (CROs) conducting medium- to high-throughput preclinical investigations.
Because longitudinal preclinical protocols often require standardized dosing or repeated culture additions over several weeks, the TB-500 10mg format minimizes batch-to-batch variation by supplying a larger quantity of peptide from a single, unified lyophilization run. This minimizes experimental noise when evaluating cellular kinetics, cytoskeletal remodeling, and tissue repair pathways.
PX1 Research manufactures and packages high-grade research peptides under strict quality controls to ensure structural integrity and lot-to-lot consistency across all analytical batches. Researchers utilizing the 10mg vial configuration benefit from standardized molarity and predictable solubility profiles across diverse buffer environments.
TB-500 is a synthetic derivative or full-length representation of Thymosin Beta-4 (Tβ4), a naturally occurring 43-amino-acid peptide encoded by the TMSB4X gene. Tβ4 is the primary G-actin sequestering molecule in eukaryotic cells, maintaining a monomeric actin pool essential for rapid cell motility, cytoskeletal reorganization, and cellular architecture maintenance.
Preclinical investigations demonstrate that TB-500 binds unpolymerized G-actin in a 1:1 complex, regulating actin filament polymerization dynamics during cell migration. In vitro models have shown that this interaction accelerates endothelial cell migration, promotes capillary-like tube formation (angiogenesis), and modulates inflammatory cytokine expression during soft-tissue and muscle-fiber recovery studies.
In rodent models of tissue injury, researchers investigate TB-500 for its ability to promote focal adhesion turnover and downregulate fibrotic signaling molecules, such as TGF-beta, thereby reducing scar tissue formation. Detailed pathways and receptor interaction targets can be explored further in the PX1 research library.
Accurate reconstitution is vital for maintaining target concentrations and ensuring reproducible delivery in experimental protocols. Reconstituting a tb-500 10mg lyophilized vial requires precise volumetric measurement of an appropriate diluent, such as Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% Sodium Chloride.
The final concentration of the solution depends directly on the volume of diluent introduced into the 10mg vial:
• Reconstitution with 1.0 mL Diluent: Yields a concentration of 10.0 mg/mL (10.0 mcg/µL). This dense concentration is preferred for micro-volume liquid handling systems or high-concentration stock aliquots. • Reconstitution with 2.0 mL Diluent: Yields a concentration of 5.0 mg/mL (5.0 mcg/µL). This intermediate concentration offers ideal volumetric control for standard micro-pipetting into cell culture media. • Reconstitution with 3.0 mL Diluent: Yields a concentration of 3.33 mg/mL (3.33 mcg/µL). This lower concentration provides maximum volumetric accuracy when dispensing minute mass increments across large experimental cohorts.
To quickly verify custom volumes and concentrations for complex assay setups, researchers are encouraged to utilize our interactive reconstitution calculator.
To preserve peptide stability and prevent physical degradation, strict handling protocols must be observed following reconstitution. Lyophilized TB-500 remains stable at -20°C to -80°C for long-term storage, protected from light and moisture ingress. Upon reconstitution, peptides are vulnerable to enzymatic cleavage, aggregation, and temperature-induced hydrolysis.
Repeated freeze-thaw cycles significantly alter secondary peptide structures and induce aggregation, rendering stock solutions variable over time. For protocols extending beyond 48 to 72 hours, investigators should immediately divide the reconstituted stock into single-use micro-aliquots using sterile, polypropylene microcentrifuge tubes.
Reconstituted solutions containing bacteriostatic water may be stored at 2°C to 8°C for up to 28 days without significant loss of analytical potency. If sterile water or saline without preservatives is utilized, aliquots must be frozen immediately at -20°C or below and thawed once prior to immediate experimental deployment.
Selecting the appropriate vial mass is a critical consideration in experimental design, balancing usage rate against stability constraints. While a 10mg vial provides superior cost-efficiency per milligram and eliminates multi-vial reconstitution steps for large-scale studies, smaller unit sizes may be better suited for limited-scope exploratory assays.
For small-scale in vitro assays or short-term preliminary trials where total consumption is below 2mg–5mg over a 14-day period, utilizing 2mg or 5mg vials limits the duration the reconstituted peptide spends in solution, reducing the risk of accidental contamination or ambient degradation.
Conversely, when conducting high-throughput screening or extended animal model studies requiring continuous dosing across multiple test groups, the 10mg vial ensures chemical consistency from a single analytical lot. Researchers can browse all available unit sizes and concentrations within our complete catalog of peptides.
PX1 Research enforces rigorous quality assurance metrics to ensure that every batch of TB-500 meets stringent laboratory parameters. Each lot undergoes strict testing protocols in an ISO 17025 accredited analytical facility to verify mass identity, chemical purity, and residual impurity limits.
Purity is assessed via High-Performance Liquid Chromatography (HPLC), guaranteeing a minimum purity threshold of ≥98.0%. Molecular identity is confirmed through Electrospray Ionization Mass Spectrometry (ESI-MS), matching the observed molecular weight against the theoretical sequence mass. Additionally, bacterial endotoxin testing via LAL assay ensures levels remain below <0.5 EU/mg.
Transparency is fundamental to reliable scientific research. Investigators can access and download lot-specific documentation directly via our dedicated Certificate of Analysis (COA) portal by entering their specific lot number.
Within preclinical regenerative biology, researchers frequently compare TB-500 with other specialized signaling peptides to analyze distinct pathways of soft-tissue and cellular recovery. While TB-500 focuses primarily on actin sequestration and cell migration, complementary peptides operate through entirely distinct molecular cascades.
For instance, BPC-157 5mg is widely investigated for its modulation of FAK and paxillin signaling pathways, nitric oxide synthesis, and gut mucosal repair mechanisms. In contrast, copper-binding peptides like GHK-Cu 50mg operate by regulating gene transcription associated with collagen synthesis, glycosaminoglycan production, and remodeling of extracellular matrix (ECM) architecture.
Additionally, growth factor secretagogues such as CJC-1295 influence systemic regenerative signaling by upregulating endogenously released growth hormones. Understanding the functional differences among these target mechanisms allows laboratories to design highly targeted multi-compound or comparative assay matrices.
PX1 Research operates state-of-the-art, GMP-compliant manufacturing facilities based in the United States. Every vial of TB-500 undergoes strict quality controls, from raw amino acid synthesis to final sterile lyophilization and vial sealing.
To support institutional timelines and uninterrupted experimental workflows, PX1 offers same-day dispatch for orders placed Monday through Friday, shipping directly from distribution hubs in California and Arizona. Institutional accounts and high-volume commercial research facilities can inquire about customized fill sizes, bulk packaging, and enterprise pricing through our wholesale lab portal.
All products supplied by PX1 Research are strictly designated for laboratory research use only. They are not intended for human or veterinary use, medical diagnostic procedures, or clinical administration.
What is the recommended storage temperature for a lyophilized 10mg TB-500 vial?
Unreconstituted, lyophilized TB-500 10mg vials should be stored at -20°C for short- to medium-term preservation, or at -80°C for long-term storage up to 24 months. Keep vials protected from direct light and moisture.
How long remains a reconstituted 10mg TB-500 vial stable at 2°C–8°C?
When reconstituted with Bacteriostatic Water containing 0.9% benzyl alcohol, stock solutions retain analytical potency for up to 28 days when maintained continuously at 2°C–8°C. Solutions reconstituted with unpreserved sterile water or saline should be used immediately or micro-aliquoted and frozen.
What is the exact molecular mass of TB-500?
Full-length synthetic Thymosin Beta-4 has a theoretical molecular weight of approximately 4963.5 Da. Electrospray Ionization Mass Spectrometry (ESI-MS) reports included on the lot-matched COA confirm this mass specification.
How do I calculate the concentration of TB-500 when adding 2 mL of diluent to a 10mg vial?
Adding 2.0 mL of sterile diluent to a 10mg lyophilized vial yields a final concentration of 5.0 mg/mL (5.0 micrograms per microliter). You can verify specific volumetric calculations using our online reconstitution calculator.
What endotoxin limits are verified for PX1 Research TB-500 10mg vials?
Every lot of PX1 Research TB-500 undergoes chromogenic LAL endotoxin testing and is verified to contain less than 0.5 EU/mg, ensuring suitability for sensitive cell culture and in vivo animal models.
Can reconstituted TB-500 stock solutions undergo multiple freeze-thaw cycles?
No. Repeated freeze-thaw cycles cause structural denaturation and peptide aggregation. Reconstituted stock solutions intended for extended use should be immediately divided into single-use micro-aliquots before initial freezing.
How can I obtain a copy of the Certificate of Analysis (COA) for my TB-500 lot?
Lot-matched Certificates of Analysis are publicly accessible on our website. Enter the lot number printed on your vial label into the PX1 COA lookup tool to view HPLC and MS testing reports.
What is the primary structural difference between TB-500 and native Thymosin Beta-4?
While the term TB-500 often refers to the active truncated domain (Ac-LKKTETQ) responsible for actin binding, PX1 Research provides high-purity synthetic sequences that accurately replicate the functional domain activity tested in peer-reviewed cell migration models.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.